Thijs Cohen Tervaert
Partner at Inkef
Thijs Cohen Tervaert
Partner at Inkef
Amsterdam, North Holland
Overview
Work Experience
Board Member
2023 - Current
iOnctura is a clinical stage biopharmaceutical company dedicated to delivering innovative cancer treatments to patients with unmet medical need.
Partner
2023
Director
2019 - 2022
Associate
2016 - 2018
Board Member
2022
Calypso Biotech is an immunotherapy biotech company, spin-off from Merck Serono, that discovers and develops monoclonal antibodies for the treatment of immune pathologies with large unmet medical needs
Board Member
2022
TargED Biopharmaceuticals B.V. is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.
Board Member
2019
Discovery and development of drugs and delivery technologies for the treatment of diseases affecting the ear, including hearing loss
Board Observer
2018
Castor EDC is a user-friendly Electronic Data Capture platform being used by medical researchers worldwide. With the help of its system, Castor allows researchers to streamline the clinical trial process and use their data to its full potential.
Board Director
2018
Board Observer
2016 - 2018
Board Member
2019 - 2022
Aidence develops and markets AI-enabled automated analysis medical images analysis used by healthcare specialists to help their patients. Acquired by RadNet.
Board Observer
2019 - 2020
First in class anti-FGFR3 mAb for the treatment of advanced bladder cancer. Assets acquired by Fusion Pharma
Consultant
2010 - 2016
Education
Doctor of Medicine - MD
2002 - 2008